IL6 and acute respiratory distress syndrome: Concordantly, IL6 promoter variant is associated with reduced severity of ARDS (Martín-Loeches et al., 2012), likewise, IL-1 receptor antagonist-null mice have delayed resolution of lung inflammation in ARDS (Hudock et al., 2012).